{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcF: >450 msec to <=480 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcF: >480 msec to <=500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcF: >500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcF: IFB >30 msec to <=60 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcF: IFB >60 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcB: >450 msec to <=480 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcB: >480 msec to <=500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcB: >500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcB: IFB >30 msec to <=60 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"title":"QTcB: IFB >60 msec"}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"description":"The QT interval data was corrected for heart rate using 2 correction methods (Fridericia - QTcF and Bazett - QTcB). The treatment period was defined as the period from first administration of study drug up 30 days after last administration. msec=milliseconds, IFB=increase from baseline.","groups":[{"description":"Patients with NET of lung origin received surufatinib 300 mg orally QD in treatment cycles of 28 days starting on C1D1 until disease progression, death, unacceptable toxicity, withdrawal of consent or lost to follow-up.","id":"OG000","title":"Cohort A (NET, Lung)"},{"description":"Patients with NET of small bowel origin received surufatinib 300 mg orally QD in treatment cycles of 28 days starting on C1D1 until disease progression, death, unacceptable toxicity, withdrawal of consent or lost to follow-up.","id":"OG001","title":"Cohort B (NET, Small Bowel)"},{"description":"Patients with NET of non-small bowel, non-pancreas, and non-lung origin received surufatinib 300 mg orally QD in treatment cycles of 28 days starting on C1D1 until disease progression, death, unacceptable toxicity, withdrawal of consent or lost to follow-up.","id":"OG002","title":"Cohort C (NET, Other)"},{"description":"Patients with NET of any origin received a single dose of drug cocktail (midazolam 2.5 mg, fexofenadine 30 mg and rosuvastatin 10 mg) on Day -2 followed by surufatinib 300 mg orally QD from C1D1 to C1D14. On C1D15, a single dose of surufatinib 300 mg and a single dose of drug cocktail as above was administered. Patients received surufatinib 300 mg orally QD from C1D16 until disease progression, death, unacceptable toxicity, withdrawal of consent or lost to follow-up.","id":"OG003","title":"Cohort D (NET, Any)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The safety analysis set included all patients who received at least 1 dose of surufatinib. Only those patients with data collected are reported.","reportingStatus":"POSTED","timeFrame":"From the first dose of study drug (Day 1) up to 30 days after last dose of study drug, approximately 33 months","title":"Number of Patients With Potentially Clinically Significant Corrected QT Interval (QTc) During Treatment","type":"SECONDARY","unitOfMeasure":"Participants"}